ASP Isotopes EPS ASPI
Diluted earnings per share by quarter and over the last twelve months, from 2022.
- Last 12 months, to Jun 30, 2026
- −$1.09
- Latest quarter, Q2 FY26
- −$0.27
- Fiscal year 2025
- −$1.91
ASP Isotopes' earnings per share was −$1.09 over the twelve months to Jun 30, 2026.
In its latest quarter, Q2 FY26, it was −$0.27.
Earnings per share over time
Fiscal year by fiscal year
| Fiscal year | EPS | Change |
|---|---|---|
| FY2025 | −$1.91 | n/a |
| FY2024 | −$0.66 | n/a |
| FY2023 | −$0.50 | n/a |
| FY2022 | −$0.18 | n/a |
Each fiscal year is the twelve months to its fourth quarter.
Quarter by quarter
| Quarter | Ended | EPS | On a year earlier | Last 12 months |
|---|---|---|---|---|
| Q2 FY26 | −$0.27 | n/a | −$1.09 | |
| Q1 FY26 | −$0.06 | n/a | −$1.85 | |
| Q4 FY25 | −$0.61 | n/a | −$1.91 | |
| Q3 FY25 | −$0.15 | n/a | −$1.44 | |
| Q2 FY25 | −$1.03 | n/a | −$1.41 | |
| Q1 FY25 | −$0.12 | n/a | −$0.62 | |
| Q4 FY24 | −$0.14 | n/a | −$0.66 | |
| Q3 FY24 | −$0.12 | n/a | −$0.62 | |
| Q2 FY24 | −$0.24 | n/a | −$0.64 | |
| Q1 FY24 | −$0.16 | n/a | −$0.54 | |
| Q4 FY23 | −$0.10 | n/a | −$0.50 | |
| Q3 FY23 | −$0.14 | n/a | −$0.46 |
Against its peers
Companies in Chemicals nearest ASP Isotopes' size, closest first, today.
| Company | EPS, 12 months | Growth |
|---|---|---|
| ASPIASP Isotopes | −$1.09 | |
| NAGENiagen Bioscience | $0.18 | −14% a year |
| FTKFlotek Industries | $0.99 | +125% a year |
| FTLFFitlife Brands | $0.62 | −23% a year |
| CRONCronos | $0.20 | +300% a year |
| ROGRogers | $1.75 | |
| BTMDbiote | $0.10 | −89% a year |
| NGVTIngevity | $1.47 | |
| IOSPInnospec | $4.90 | +545% a year |
| FULFuller H B | $3.59 | +72% a year |
| WDFCWD 40 | $6.58 | +4% a year |
| Peer median | $1.23 |
What the EPS figure tells you
Net income divided by diluted shares. The denominator of PE.
One-off charges and gains swing it. The TTM view smooths a single odd quarter.
More on ASP Isotopes
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.